BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24919657)

  • 1. Hyperglycemia to nephropathy via transforming growth factor beta.
    Garud MS; Kulkarni YA
    Curr Diabetes Rev; 2014 May; 10(3):182-9. PubMed ID: 24919657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLUT1 regulation of the pro-sclerotic mediators of diabetic nephropathy.
    Heilig CW; Deb DK; Abdul A; Riaz H; James LR; Salameh J; Nahman NS
    Am J Nephrol; 2013; 38(1):39-49. PubMed ID: 23817135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenetic mechanisms of diabetic nephropathy.
    Schena FP; Gesualdo L
    J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S30-3. PubMed ID: 15938030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
    Iglesias-de la Cruz MC; Ziyadeh FN; Isono M; Kouahou M; Han DC; Kalluri R; Mundel P; Chen S
    Kidney Int; 2002 Sep; 62(3):901-13. PubMed ID: 12164872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C.
    Ha H; Kim KH
    Diabetes Res Clin Pract; 1999 Sep; 45(2-3):147-51. PubMed ID: 10588367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular bases of diabetic nephropathy].
    Lagranha CJ; Fiorino P; Casarini DE; Schaan BD; Irigoyen MC
    Arq Bras Endocrinol Metabol; 2007 Aug; 51(6):901-12. PubMed ID: 17934656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic nephropathy: where hemodynamics meets metabolism.
    Forbes JM; Fukami K; Cooper ME
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
    Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
    Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic nephropathy: mechanisms of renal disease progression.
    Kanwar YS; Wada J; Sun L; Xie P; Wallner EI; Chen S; Chugh S; Danesh FR
    Exp Biol Med (Maywood); 2008 Jan; 233(1):4-11. PubMed ID: 18156300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of growth factors in diabetic kidney disease.
    Chiarelli F; Gaspari S; Marcovecchio ML
    Horm Metab Res; 2009 Aug; 41(8):585-93. PubMed ID: 19452424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes.
    Huang C; Kim Y; Caramori ML; Fish AJ; Rich SS; Miller ME; Russell GB; Mauer M
    Diabetes; 2002 Dec; 51(12):3577-81. PubMed ID: 12453917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephropathy in diabetes.
    Satirapoj B
    Adv Exp Med Biol; 2012; 771():107-22. PubMed ID: 23393675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model.
    Ohtomo S; Nangaku M; Izuhara Y; Takizawa S; Strihou Cv; Miyata T
    Nephrol Dial Transplant; 2008 Apr; 23(4):1166-72. PubMed ID: 17967803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of TGF-beta in pathogenesis of diabetic nephropathy.
    Pantsulaia T
    Georgian Med News; 2006 Feb; (131):13-8. PubMed ID: 16575121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy.
    Sun YM; Su Y; Li J; Wang LF
    Biochem Biophys Res Commun; 2013 Apr; 433(4):359-61. PubMed ID: 23541575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gremlin Regulates Podocyte Apoptosis via Transforming Growth Factor-β (TGF-β) Pathway in Diabetic Nephropathy.
    Wang XB; Zhu H; Song W; Su JH
    Med Sci Monit; 2018 Jan; 24():183-189. PubMed ID: 29315280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II and growth factors in the pathogenesis of diabetic nephropathy.
    Rincon-Choles H; Kasinath BS; Gorin Y; Abboud HE
    Kidney Int Suppl; 2002 Dec; (82):S8-11. PubMed ID: 12410848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up.
    Chen S; Jim B; Ziyadeh FN
    Semin Nephrol; 2003 Nov; 23(6):532-43. PubMed ID: 14631561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.